Empower Pharmacy
Houston-based dual-registered compounding pharmacy with a large 503B outsourcing footprint. A common backbone for the higher-disclosure compounded-GLP-1 telehealth programs.
Footprint
Empower runs both a 503A patient-specific compounding pharmacy and a 503B FDA-registered outsourcing facility — meaning they can fill individualized prescriptions as well as prepare batched compounded medications under cGMP-equivalent standards. The 503B side is regularly inspected by FDA.
Quality systems
Compounded sterile injectables undergo per-batch sterility (USP <71>), bacterial-endotoxin (USP <85>), and potency (HPLC) testing. Empower publishes its 503B Bulks List participation status and FDA inspection observations.
Why it matters for patients
Providers that disclose Empower as a named partner are a positive signal for the Pharmacy Traceability pillar of our rubric, especially when paired with CoA-on-request and a documented 503A vs 503B routing policy by patient.
Disclosed partner providers
- NexLifescore 96/100